Raise XT Study
STUDY AND PROTOCOL NUMBER
RAISE XT
RA101495-02-302
STUDY DETAILS
The RAISE-XT study is an open-label extension study to evaluate the long-term efficacy, safety, and tolerability of zilucoplan in subjects with gMG who have previously participated in a qualifying Ra Pharmaceuticals sponsored zilucoplan study.
FURTHER INFORMATION
ClinicalTrials.gov Identifier: NCT04225871
Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis